ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,631.22
      0.28%
      US Tech 100
      19,884.80
      0.46%
      Dow Jones
      40,211.72
      0.53%
      Brent Oil
      83.84
      -0.59%
      Bitcoin
      63,663.44
      -1.83%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Mesoblast Limited (MESO)

      7. Mesoblast Limited (MESO) News

      MESO

      Mesoblast (MESO)

      Mesoblast Limited
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:MESO
      DateTimeSourceHeadlineSymbolCompany
      09/08/20207:32AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      09/04/20206:00AMGlobeNewswire Inc.Data Safety Monitoring Board Recommends Continuation of Remestemcel-L Phase 3 Trial in COVID-19 Patients With Acute Respirato...NASDAQ:MESOMesoblast Limited
      09/03/20206:02AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      09/02/20206:00AMGlobeNewswire Inc.Mesoblast Receives Ethics Approval to Treat COVID-19 Patients in AustraliaNASDAQ:MESOMesoblast Limited
      08/26/20206:53PMGlobeNewswire Inc.Mesoblast Reports Substantial Operational Progress and Financial Results for the Year Ended June 30, 2020NASDAQ:MESOMesoblast Limited
      08/25/20208:37PMGlobeNewswire Inc.Mesoblast 2020 Full Year Financial Results WebcastNASDAQ:MESOMesoblast Limited
      08/25/20206:01AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      08/17/20206:26AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      08/14/20206:00AMGlobeNewswire Inc.U.S. FDA Advisory Committee Votes Nine to One in Favor of Remestemcel-L (Ryoncil™) for Efficacy in Children With Steroid-Re...NASDAQ:MESOMesoblast Limited
      08/12/20206:02AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      08/11/20206:00AMGlobeNewswire Inc.Update on Scheduled FDA Advisory Committee MeetingNASDAQ:MESOMesoblast Limited
      08/10/20208:44AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      07/30/20206:00AMGlobeNewswire Inc.Mesoblast Provides Remestemcel-L Update and Quarterly Activity ReportNASDAQ:MESOMesoblast Limited
      07/27/20207:18AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      07/27/20206:23AMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:MESOMesoblast Limited
      07/24/20206:00AMGlobeNewswire Inc.Executive Leadership Expanded Ahead of First Potential U.S. Product LaunchNASDAQ:MESOMesoblast Limited
      07/21/20205:33PMGlobeNewswire Inc.FDA Advisory Committee Sets Review Date for Mesoblast’s remestemcel-L in Pediatric Steroid-Refractory Acute Graft Versus Ho...NASDAQ:MESOMesoblast Limited
      07/10/20206:06AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      07/07/20206:02AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      07/06/20206:00AMGlobeNewswire Inc.Expanded Access Protocol Initiated for Compassionate Use of Remestemcel-L in Children With Multisystem Inflammatory Syndrome ...NASDAQ:MESOMesoblast Limited
      06/26/20206:48AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      06/18/20206:02AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      06/01/20206:00AMGlobeNewswire Inc.Remestemcel-L Improves Respiratory and Functional Outcomes in Patients With Inflammatory Lung DiseaseNASDAQ:MESOMesoblast Limited
      05/27/20205:53PMGlobeNewswire Inc.Mesoblast Reports Strong Financial Position and Substantial Operational Progress For the Period Ended March 31, 2020NASDAQ:MESOMesoblast Limited
      05/26/20206:00AMGlobeNewswire Inc.Mesoblast to Host Analyst Call on Financial Results for Period Ended March 31, 2020NASDAQ:MESOMesoblast Limited
      05/25/20207:00AMGlobeNewswire Inc.Clinical Outcomes Using RYONCIL™ (remestemcel-L) in Children and Adults With Severe Inflammatory Graft Versus Host Disease ...NASDAQ:MESOMesoblast Limited
      05/13/20206:00AMGlobeNewswire Inc.Mesoblast Successfully Completes Financing to Scale-Up Manufacturing of Remestemcel-L for COVID-19 ARDSNASDAQ:MESOMesoblast Limited
      05/06/20206:00AMGlobeNewswire Inc.First Patients Dosed in Phase 2/3 Randomized Controlled Trial of Mesoblast’s Remestemcel-l for COVID-19 Acute Respiratory ...NASDAQ:MESOMesoblast Limited
      04/30/20207:00AMGlobeNewswire Inc.Phase 2/3 Randomized Controlled Trial of Remestemcel-L in 300 Patients With COVID-19 Acute Respiratory Distress Syndrome Begi...NASDAQ:MESOMesoblast Limited
      04/24/20206:00AMGlobeNewswire Inc.83% Survival in COVID-19 Patients with Moderate/Severe Acute Respiratory Distress Syndrome Treated in New York with Mesoblast...NASDAQ:MESOMesoblast Limited
       Showing the most relevant articles for your search:NASDAQ:MESO